|
|
 Friday, September 19, 2014 |
Join us for the Petrie-Flom Center's 2014 Annual Open House!
|
October 6, 2014 5:30 - 7:00 PM
Come learn more about what the Petrie-Flom Center does and how you can get involved at this gathering for faculty, colleagues, and students with shared interests in health law policy, biotechnology, and bioethics. We will review our sponsored research portfolio, introduce our staff and fellows, describe various opportunities for students and others, and demonstrate key features on our website. And of course, we'll eat, drink, and be merry. Hope to see you there!
|
| Petrie-Flom Center Executive Director Named Newest Member of SACHRP |
Holly Fernandez Lynch, J.D., M.Bioethics, Executive Director of the Petrie-Flom Center at Harvard Law School, has been appointed by Secretary of Health and Human Services Sylvia Burwell to a four-year term as a member of the Secretary's Advisory Committee on Human Research Protections (SACHRP). SACHRP is a Federal Advisory Committee charged with providing expert advice and recommendations to the Secretary on issues and topics pertaining to the protection of human research subjects. To date, SACHRP has focused its attention on areas such as research involving children, prisoners, and individuals with impaired decision-making capacity; informed consent and the use of biospecimens; harmonization of human subjects regulations and guidance; the reduction of regulatory burden; the HIPAA Privacy Rule; community-engaged research, and accreditation.
Holly will bring a range of expertise in human subjects research to this new role from her prior experience in private practice counseling pharmaceutical company clients on clinical research issues, her work as a bioethicist advising the Division of AIDS on research ethics in the conduct of HIV/AIDS trials, and her service as a staff member supporting President Obama's Commission for the Study of Bioethical Issues, where she worked on Ethically Impossible: STD Research in Guatemala from 1946-1948. Holly has served as a member of the Institutional Review Board at The Fenway Institute, and as a member of expert working groups at the Multi-Regional Clinical Trials Center at Harvard. Alongside Petrie-Flom Center Faculty Director I. Glenn Cohen, Holly is Co-Lead of the Law and Ethics Initiative of the Football Players Health Study at Harvard University, as well as Co-Lead of the Center's Involvement with the Regulatory Foundations, Ethics, and Law Program of Harvard Catalyst, Harvard's Clinical and Translational Science Center. She is also co-editor, with I. Glenn Cohen, of Human Subjects Research Regulation: Perspectives on the Future (MIT Press 2014).
Please join us in congratulating Holly on her new appointment!
|
|
News & Scholarship from Petrie-Flom Associates
|
 FDA Proposal for Regulating Laboratory Diagnostics Could Improve Patient Care
Rachel Sachs (Academic Fellow)
Hastings Center Bioethics Forum, September 4, 2014
From the article:
[...] [T]he FDA's proposal [to regulate laboratory-developed tests] ... could improve patient care by collecting, for the first time, clinical validity data on tens of thousands of LDTs in current use. And by using an extensive system of carve-outs, the FDA is seeking to minimize potential harms for diagnostic innovation. Understanding these key portions of the FDA's disclosure to Congress is critical to a full policy discussion of the situation. [...]
Read the full article.
 Harvard Law Professor: Medicalization of Death is ProblematicCourtney Coren, interviewing I. Glenn Cohen (Faculty Director) Newsmax TV, September 17, 2014 From the interview: [...] Cohen: The idea here is that we think that execution is the state ending someone's life, and we don't want to make that look like a medical procedure when it's not a medical procedure. The American Medical Association as well as many other medical associations have taken a firm position that lethal injection and participating in execution in general is incompatible with being a doctor because it's primum non nocere, 'first do no harm.' [...]
Watch the full interview. GLOBAL: New medical tourism book from Glenn Cohen International Medical Travel Journal, discussing I. Glenn Cohen September 10, 2014 From the article:
[...] Glenn Cohen's new book "Patients with Passports: Medical Tourism, Law, and Ethics" is from Oxford University Press. It claims to be the first comprehensive legal and ethical analysis of medical tourism; examining both the legal and ethical issues raised by medical tourism and how the two interact. It provides data and explanations of the industry and tackles what the publisher says are the most prevalent legal and ethical issues facing medical tourism today. [...] Read the full article. An Interview with I. Glenn Cohen on Controversial Health Issues In an interview with PBS, Faculty Director I. Glenn Cohen, sat down with Tavis Smiley to discuss important health issues, such as experimental Ebola drugs and prescription opiate use in the U.S.
From the interview:
[...] Smiley: Let me start with your assessment of - it's been a little while now - your assessment of how this Ebola crisis has been handled to date.
Cohen: So I think the general sense of people who work in public health is that it's not been a very strong handling of it. There were about 20 Ebola outbreaks since 1976. This was predictable that this was coming. You had the first index case in December 2013 of this outbreak, but it took until August for the WHO to declare a public health emergency and only more recently has it issued its roadmap. And in general, I think most people feel as though this could have been contained much more quickly. And one of the ways to have done that would have been to do more capacity-building of the infrastructure for healthcare in many of these countries. [...]
Watch the full interview.
Big Data: The Conversation Continues (Part 1)
David Bates and I. Glenn Cohen
Health Affairs Conversations, August 8, 2014
In a Health Affairs podcast, David Bates and I. Glenn Cohen discuss big data and the Health Affairs July issue on the topic.
Listen to the full podcast.
Top
|
Come join the conversation at Bill of Health! During the last two weeks, our bloggers have been discussing:
Health insurance, health care reform/finance:
-
"Discrimination on the Basis of Health Status in Health Insurance: 'Market-Norm or Necessity'?" ( here) - "What's to become of population health?" (here)
- "To Watch: Rural Enrollment on Exchanges" (here)
- "8 Facts (and some pretty graphs) that explain what's wrong with American Healthcare" (here)
Reproductive Health/Rights:
-
"Medical Malpractice in Reproductive-Choice Procedures" ( here)
Pharmaceuticals:
- "Gilead Announces Access Program for Hepatitis C Drug" (here)
Food safety and regulation:
- "Questioning Quorn" (here)
Bioethics:
- "Can Someone's Sex be Situational?" (here)
General health law/policy:
- "King v. Governor of the State of New Jersey: Applying the First Amendment to Laws Regulating Physician Speech" (here)
- "Clinicians, care, and conflicts of interest in the sports medicine environment" (here)
- "Defining Public Health Emergencies" (here)
- "Of Morals and Smartphones" (here)
- "What Is (or Isn't) a Public Health 'Emergency'?" (here)
- "Asking the Right Right Question about Football - Why do Some NFL Players Abuse Their Partners?" (here)
- "Asking the Right Question about Football" (here)
- "Ebola and the Return of Quarantine" (here)
- "The Expressive Dimension of Donor Deferral" (here)
If you'd like to join us as a guest blogger or if you have something you'd like us to post, please contact us at
[email protected].
Top
|
|
Health Law Policy & Bioethics Workshops
|
Upcoming presenters for the Health Law Policy and Bioethics Workshop, this year run by Professors Cohen and Elhauge, include:
September 22: Thomas McGuire, Harvard Medical School
September 29: Benjamin Roin, MIT Sloan School of Management
November 03: Matt Lamkin, University of Tulsa College of Law
Presentation Topic:
"Regulating Identity: Medical Regulation as Social Control"
Papers will be posted to our website one week in advance. A full list of the workshop schedule is available on our website.
Top
|
Check out our website for a more complete listing of events scheduled in 2014-2015.
We're adding new events all the time! And remember, you can find materials from many of our events, including slide presentations and full event videos, online in our events archive.
|
A Conversation with the HHS Office of the Inspector General
Tuesday, September 30, 2014, 12:00 PM
Wasserstein Hall, Room 3018,1585 Massachusetts Ave., Cambridge, MA
Please join the Petrie-Flom Center for a conversation with the Boston office of the U.S. Department of Health and Human Services Office of the Inspector General (OIG), Office of Evaluation and Inspections. OIG has for decades served as the foremost government watchdog of federal healthcare programs, overseeing Medicare, Medicaid, the Food and Drug Administration, the National Institutes of Health, and the Centers for Disease Control and Services. Among other topics, the Boston office's recent work has focused on the labeling of dietary supplements and human subjects protections, including the informational risks associated with biospecimen research and other topics.
Come hear about the work of the OIG, its role in the Department of Health and Human Services, and some of its current and past projects. We will be joined by Joyce Greenleaf, MBA, Regional Inspector General, and Jessica Fargnoli, MPH, Program Analyst. Matthew Lawrence will moderate.
Lunch and refreshments will be served. Co-sponsored by the Petrie-Flom Center and Harvard Catalyst.
|
|
Monday, October 20, 2014, 8:00 AM - 5:00 PM
Washington, DC
The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School and the Food and Drug Law Institute are pleased to announce this collaborative academic symposium. The full agenda is now available on our website. Registration for this event is now open online. A limited number of free seats are available to Harvard affiliates. For more information or to request a seat, please email us at [email protected].
|
Monday, October 6, 2014, 4:00 PM
New healthcare start-ups face a range of legal and ethical challenges as they develop new products and services and solicit financial support from investors. Building on the success of the President's Challenge at the Harvard Innovation Lab, which invites teams of Harvard students to develop innovative solutions to a range of global issues including healthcare accessibility and affordability, the Petrie-Flom Center will host a discussion of the issues that past winners of the President's Challenge have faced as they seek to move their ideas out of the lab and into the private sector.
Panelists include:
-
Patrick Ho, HLS '12, Co-Founder, VP of Operations and Legal Affairs, Vaxess Technologies
-
Dr. Hitesh Tolani, Virtudent
-
John Quelch, Charles Edward Wilson Professor of Business Administration, HBS
-
Gordon Jones, Managing Director, i-lab
-
Moderator: I. Glenn Cohen, Petrie-Flom Center and HLS
The panel discussion will be followed by the Petrie-Flom Center's Annual Open House reception. Join us to learn more about the Petrie-Flom Center's work!
|
October 6, 2014 5:30 - 7:00 PM
Come learn more about what the Petrie-Flom Center does and how you can get involved at this gathering for faculty, colleagues, and students with shared interests in health law policy, biotechnology, and bioethics. We will review our sponsored research portfolio, introduce our staff and fellows, describe various opportunities for students and others, and demonstrate key features on our website. And of course, we'll eat, drink, and be merry. Hope to see you there!
|
Book Launch: Human Subjects Research Regulation: Perspectives on the Future
Wednesday, October 22, 2014, 12:00 PM
Harvard Law School Library, Langdell Hall, Caspersen Room, 1557 Massachusetts Ave., 4th floor, Cambridge, MA
Please join us for a discussion of the book, pending efforts to amend federal research regulations, and some of the biggest unresolved questions in this space:
This event is free and open to the public. A light lunch will be served.
Co-sponsored by the Harvard Law School Library.
|
|
 REGISTER NOW!
2015 Annual Conference: Law, Religion, and American Health Care
May 8 - 9, 2015, 8:00 AM - 5:00 PM
Wasserstein Hall, Milstein East BC,1585 Massachusetts Ave., Cambridge, MA
The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School is pleased to announce plans for our 2015 annual conference, this year entitled: "Law, Religion, and American Health Care."
Conference Description
Religion and medicine have historically gone hand in hand, but increasingly have come into conflict in the U.S. as health care has become both more secular and more heavily regulated. Law has a dual role here, simultaneously generating conflict between religion and health care, for example through new coverage mandates or legally permissible medical interventions that violate religious norms, while also acting as a tool for religious accommodation and protection of conscience.
This conference, and anticipated edited volume, will aim to: (1) identify the various ways in which law intersects with religion and health care in the United States; (2) understand the role of law in creating or mediating conflict between religion and health care; and (3) explore potential legal solutions to allow religion and health care to simultaneously flourish in a culturally diverse nation.
Call for Abstracts
We welcome submissions on both broad conceptual questions and more specific policy issues. Potential topics might include:
- Analysis of the First Amendment, the Religious Freedom Restoration Act, and other federal, state, and local legal provisions that come into play at the intersection between religion and health care
- The Affordable Care Act and employer-based health care coverage, including the contraceptives mandate and related court decisions
- Legal obligations and accommodations of religious health care organizations
- Protection (or not) of health professional conscience
- Health care decision-making for minors with religious parents
- Religious objection v. discriminatory behavior
- Informed consent and information flow, e.g., religious objection to providing certain information, inclusion of religious information in consent disclosures, etc.
- "Medicalization" of religious beliefs, e.g., regulation of homosexual conversion therapy
- Abortion policy, including clinic protests and protections, and its relationship to religion
- Embryonic stem cell policy and its relationship to religion
- End-of-life care, including assisted suicide, and its relationship to religion
- Complicity as both a legal and religious concept
- Comparative analysis, e.g., between professions, health care practices, countries, etc.
If you are interested in participating, please send a 1-page abstract of the paper you would plan to present to [email protected] as soon as possible, but not later than December 1, 2014.
Additional information about abstract submission and registering for the conference can be found here. Please contact [email protected] with questions. |
Save the Date for More Upcoming Petrie-Flom Events!
-
Transparency in the Global Food System: How Much Information and to What Ends?; October 24 - 25, 2014, 8:00 AM - 2:00 PM
-
Global Reproduction: Health, Law, and Human Rights in Surrogacy and Egg Donation; Wednesday, November 5, 2014
Law of Ethics and Non-Invasive Prenatal Testing; Thursday, November 6, 2014
-
Book Launch: Patients with Passports: Medical Tourism, Law, and Ethics; Wednesday, November 19, 2014
-
Petrie-Flom Reception at 2014 PRIM&R Annual Conference December 5, 2014
-
Families Matter: Ethically, Legally, and Clinically, March 18-21, 2015
|
Look for more details on these events in future editions of this newsletter, or follow us on Facebook and Twitter to receive updates as soon as they're available!
Subscribe to our Google Calendar to stay up to date on Petrie-Flom Center events.
|
Public Ethics Forum: "Remembering Bud Relman and His Contributions to Medical Ethics"
Thursday, October 9, 2014, 4:30 - 6:00 PM
Harvard Medical School, Benjamin Waterhouse Room, Gordon Hall, 25 Shattuck Street, Boston, MA
This past June the profession of medicine lost one of its most visionary leaders, Arnold "Bud" Relman. Dr. Relman made many remarkable contributions to medicine, but for this session we will focus on his contributions to the field of medical ethics. Bud was deeply engaged in many of the most contentious ethical issues of his time, especially those related to the delivery of healthcare and to maintaining the integrity of the research enterprise. The thread that ran through the fabric of all these issues was his deep commitment to professionalism and personal ethical integrity, without which he believed the profession would fail. In both his own writing and in the encouragement he gave to others through publishing their work in the Journal, he gave these issues a voice they would not otherwise have had.
Jerome Kassirer, who succeeded Bud Relman as Editor-in-Chief of the New England Journal of Medicine, will be our guest for this session. Robert Truog will moderate. We plan to cover several of the ethical themes that occupied Dr. Relman's interests and attention, and will engage with the audience in reflecting upon Bud's life and work.
Please RSVP Here.
|
September 29 - October 1, 2014
Sheraton Commander Hotel, 16 Garden Street, Cambridge, MA
Petrie-Flom Executive Director, Holly Fernandez Lynch will be teaching a session on Ethics of Human Research.
Course themes:
- Preclinical Discovery
- Clinical and Experimental Pharmacology
- Conflicts of Interest
- Leadership and Team Dynamics in Research
- Ethics of Human Research
- Academic/Industrial Relationships in Drug Development
Eligibility
- MD, DMD, PharmD, DNP, PhD, or equivalent
- Involvement in basic or clinical research
- Endorsement from immediate supervisor
Tuition-free for Harvard-affiliated institutions. Harvard Catalyst Education Program's policy requires full attendance and completion of all activity surveys to be eligible for CME credit; no partial credit is allowed.
Utilizing both case studies and a didactic curriculum, Introduction to Translational Medicine (ITTM) is a survey course that offers an introduction to the skills necessary to embark on a career in translational research, particularly in the process of bringing an idea from the laboratory to first-in-human trials (called T1 translational research). This course focuses on the principles and practices of translational medicine as they apply to the development of a new drug (small molecules and/or biologics), device, or diagnostic. Case studies allow participants to grasp the realization of the concepts discussed. Each attendee receives training in the pre-clinical development of novel targets and leads, clinical pharmacology, the regulatory process, and design of the first-in-human clinical trial. In addition, participants learn about funding opportunities for translational research, as well as how to navigate academic/industrial collaborations that lead to the successful development of new drugs or methodologies.
|
"Autonomy's Price: Choosing Not to Choose"
Thursday, October 30, 2014, 4:30 PM
Harvard Medical School, Armenise Building, D Amphitheater, 210 Longwood Avenue, Boston, MA
Cass R. Sunstein, JD, Robert Walmsley University Professor, Harvard Law School.
The George W. Gay Lecture
is the oldest endowed lectureship at Harvard Medical School, and quite possibly the oldest medical ethics lectureship in the United States. The lectureship was established in 1917 by a $1,000 gift from Dr. George Washington Gay, an 1868 graduate of HMS. Since its inception, many of the nation's most influential physicians, scientists, researchers and social observers, including Erich Fromm, Felix Frankfurter, Margaret Mead, Elizabeth K�bler Ross, E.O. Wilson, and Joshua Lederberg have given the Gay Lecture. Elie Wiesel, Marian Wright Edelman, Paul Krugman, Nicholas Kristof and Donald Berwick have given recent Gay Lectures.
RSVP Here.
|
Thursday, October 9, 2014, 7:45 AM - 2:15 PM
Saul Farber Auditorium, Bellevue Hospital, 27th Street and First Ave, New York City, NY
Informed consent and Institutional Review Boards (IRBs) are the cornerstones of modern bioethical research but they do not solve all of the complicated issues of science, justice, and coercion that such studies raise. The NYULMC Division of Medical Ethics invites you to a provocative program on cutting-edge issues in the ethics of conducting biomedical research. Attendees will learn from leading experts and engage in discussions of current controversies, ranging from understanding 'minimal risk' in studies that involve socially vulnerable populations to the ethics of randomized controlled trials without consent. Other topics to be covered include the contemporary implications of the U.S.-led sexually transmitted disease research conducted on Guatemalans during the 1940s; new strategies and technologies for improving informed consent; and the vexing issue of compassionate use.
For more information, please click here.
|
Harvard Business School and Harvard Medical School
Application Deadline: September 29, 2014
Innovations must have credible, demonstrated evidence of their value proposition (such as cost savings, outcomes improvement, patient satisfaction, etc.); have a compelling dissemination plan; and be at the cusp of scaling.
Finalists get a case written about them, share $150,000, and have the opportunity to present at the Forum on Health Care Innovation conference in April. Please let us know if you need any other information or materials. We are happy to provide them.
We're looking for proven ideas that have the potential to do great things for the U.S. health care delivery system. It is widely known that health care innovations are much slower to disseminate than comparable solutions in other industries. We want to help speed up the process. What's your innovation?
Innovations must have credible, demonstrated evidence of their value proposition (such as cost savings, outcomes improvement, patient satisfaction, etc.); have a compelling dissemination plan; and be at the cusp of scaling.
For more information, please visit the website.
Top
|
NEW POST
CPMC-Bioethicist West Bay Region
Program in Medicine & Human Values, California Pacific Medical Center
Open until filled.
The Bioethicist West Bay Region ("WBR"), under the supervision of the Director PMHV, the Senior Ethics Scholar and CPMC Bioethicist, will be the key provider of ethics expertise to Sutter West Bay Hospitals. This position will support the Ethics Committees of Sutter West Bay Hospitals by receiving and coordinating all requests for ethics consultations, executing consultations and following up with cases after referral. The Bioethicist WBR will be responsible for educating and training the hospital ethics committees of Sutter West Bay Hospitals using materials developed by the PMHV on the basis of the consultation case model used at CPMC.
To apply online, please click here.
NEW POST
Health Policy & Administration Assistant Professor
Application Deadline: November 15, 2014
A tenure-track assistant professor position is available in the Department of Health Sciences at DePaul University starting September 2015. The successful candidate will be broadly trained in health policy and administration or management. The subfield and area of concentration are open though the department is particularly interested in applications with expertise in health policy, public policy, health care administration, health care management, health care leadership, or health care finance. A Ph.D. or equivalent degree is required. Previous teaching experience preferred.
To apply online, please click here.
NEW POST
Full-Time/Part-Time Clinical Ethicist
The Office of Ethics at Boston Children's Hospital is immediately seeking a full-time Clinical Ethicist or two part-time Clinical Ethicists. At BCH, each Clinical Ethicist provides formal and informal ethics consultations, organizes and participates in clinical ethics rounds, and collaborates with clinical teams, patients and families, to address ethical issues in pediatric health care and research. The Clinical Ethicist develops ethics resources and education and serves as a facilitator for change directed toward strengthening the Hospital staff's sense of moral responsibility and moral community.
To apply online, please click here.
NEW POST
HRPP Quality Assurance/Quality Improvement Specialist
Human Research Protections Program, Massachusetts Eye and EarOpen until filled.Under the supervision of the Director of the Human Research Protections Program (HRPP), the HRPP Quality Assurance/Quality Improvement and Education Specialist is responsible for providing on-going support and education to the clinical research community at Massachusetts Eye and Ear Infirmary and Schepens Eye Research Institute to ensure compliance with applicable institutional, FDA, OHRP, HIPAA, and GCP requirements and ethical guidelines. In addition, the incumbent works with the Director to identify, develop, and implement new QI initiatives and to perform directed and routine on-site reviews of the Human Studies Committee (HSC)-approved studies.
Notably, the Quality Assurance/Quality Improvement and Education Specialist is responsible for coordinating and overseeing the initial accreditation of Mass. Eye and Ear's HRPP, and maintaining accreditation of the HRPP thereafter, working closely with the Director, HSC and other key stakeholders throughout the organization. To apply online, please click here.
Open until filled.A perfect position for someone looking to gain experience prior to graduate training in bioethics. The Research Program Coordinator will work with two or three primary faculty members at the Johns Hopkins Berman Institute of Bioethics to coordinate and provide research support for numerous academic and empirical projects and their components. The position's major areas of focus include participating in the development of an educational course; sustaining an ethics summit collaborative; editorial and project management of a book; research support; and administrative tasks.To apply online, please click here.
Children's Ethics Center, Cincinnati Children's Hospital Medical Center
Open until filled.
Cincinnati Children's Hospital Medical Center (CCHMC) invites applications for a faculty position in clinical ethics at the rank of Assistant or Associate Professor. The faculty member is expected to be an active member of the Ethics Committee and Ethics Consultation Subcommittee. He/she will also support specialty areas such as the Fetal Care Center, Cardiac Intensive Care Unit, and/or Solid Organ Transplant Programs.
Interested applicants should send a letter of interest and a CV to:
Armand H. Matheny Antommaria, MD, PhD, FAAP
Director, Ethics Center
Cincinnati Children's Hospital Medical Center
c/o Elizabeth Kerstine
HR Consultant
Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, MLC
16056, Cincinnati, OH 45229 For more information, please click here.
Department of Bioethics, The Cleveland Clinic Foundation
Application Deadline: November 1, 2014
The Cleveland Fellowship in Advanced Bioethics (CFAB) is a two-year, full-time program designed to train the next generation of leaders in the field of bioethics. Applications will be considered from professionals with terminal post-graduate degrees in medicine, philosophy, nursing, social work, religious studies, law, and other fields related to the practice of clinical and academic bioethics. Completed applications must be submitted by November 1 and the starting date for the fellowship is July 1 of each year.
For more information and to apply, please click here.
Children's Ethics Center, Cincinnati Children's Hospital Medical Center
Open until filled.
Cincinnati Children's Hospital Medical Center (CCHMC) invites applications for a faculty position in clinical ethics at the rank of Assistant or Associate Professor. The faculty member will be expected to develop a research program that contributes to a fuller understanding of ethical issues in research. The faculty member will also be expected to participate in education and in administrative service.
Interested applicants should send a letter of interest and a CV to:
Armand H. Matheny Antommaria, MD, PhD, FAAP Director, Ethics Center Cincinnati Children's Hospital Medical Center c/o Elizabeth Kerstine HR Consultant Cincinnati Children's Hospital Medical Center, 3333 Burnet Avenue, MLC 16056, Cincinnati, OH 45229 For more information, please click here.
The Center for Ethics at Emory University seeks a bioethics scholar to direct our Master of Arts in Bioethics (MAB) program. Rank and area of specialty are open. The ideal candidate will have experience teaching bioethics at the graduate or professional level, organizational and leadership experience, and a solid record of bioethics scholarship. Experience helping build or running a masters-level program in bioethics or related field is a plus. A PhD or professional equivalent in a bioethics-related discipline, or an advanced degree in a related field with training at the masters or fellowship level in bioethics is required. The Director will teach three courses/year in the MA program, with some teaching in other Emory schools as well.
Candidates should provide a letter of interest, including a description of personal scholarship and a statement of teaching philosophy; a full CV; and the names and contact information of three references to:
Jamila Garrett-Bell
Center for Ethics, Emory University
1531 Dickey Drive
Non-procedural inquiries should be directed to Kathy Kinlaw, Center for Ethics Associate Director, at [email protected].
NEW POST
2014 Health Law Student Scholarship: The Healthcare Compliance Certification Program and the Life Sciences Compliance Program
Application Deadline: February 6, 2015
The Center for Health & Pharmaceutical Law & Policy Healthcare Compliance Certification Program 2014 Health Law Student Scholarship: The Healthcare Compliance Certification Program and the Life Sciences Compliance Program are both multi-day educational programs that address the myriad of legal and compliance issues faced by the pharmaceutical and medical device industries.
Purpose: These scholarship awards recognize promising health law students, with an aptitude for and commitment to a career in health law, focusing on legal and compliance issues within the pharmaceutical, biotech, and medical technology industries.
Eligibility: Each nominee must qualify under the following criteria:
- The nominee shall be a 2L or part-time 3L student currently enrolled in an accredited North American law school. 3L students who anticipate graduating in May or June 2015 are not eligible.
- The nominee, through his or her law school academic and clinical work and other related activities, shall demonstrate an aptitude for and commitment to a legal career in health care law within the pharmaceutical, biotech, and/or medical technology industries.
- The nominee must be available to attend either the June 8-11, 2015, Healthcare Compliance Certification Program in New Jersey, or the Fall 2015 Life Sciences Compliance Program in California.
- Multiple nominations per law school may be made.
Application: The following materials must be submitted by the nominee (the submission of additional material is not encouraged):
- A signed letter, from either the Dean, clinical program director, or law school professor teaching in a health law or related area, nominating the candidate and setting forth the basis for the nomination, including a description of the purpose and content of the class or clinical program in which the student is enrolled (please submit nomination letter electronically followed by original mailed copy).
- The nominee's current resume, including most recent GPA (electronic copy required).
- A list of all health law courses completed and those in which the nominee is currently enrolled.
- A brief personal statement of no more than two (2) typewritten pages highlighting the nominee's background, experience, and other relevant information that qualifies him or her to receive the scholarship (electronic copy required).
- Identification of which scholarship the nominee is applying for: the Healthcare Compliance Certification Program in New Jersey, or the Life Sciences Compliance Program in California.
Judging:
- All applications will be judged by members of the Seton Hall Law School Faculty. All decisions are final.
- All applications will be judged on the strength of the eligibility criteria, letter of nomination, and personal statement.
- No scholarship will be awarded if the faculty members determine that no application meets the scholarship eligibility standards.
- For the Life Sciences Compliance Program, preference will be given to nominees currently attending law school in the Western United States.
Awards: Two scholarships (each a $2,400 value) for the Healthcare Compliance Certification Program will be awarded in 2015. Scholarship recipients must attend the June 2015 Healthcare Compliance Certification Program.
One scholarship ($2,500 value) for the Life Sciences Compliance Program will be awarded in 2015. The scholarship recipient must attend the Fall 2015 Life Sciences Compliance Program.
The scholarship covers tuition, educational materials, breakfast (if applicable), lunch, and parking (if applicable) during the program. Please note that transportation and hotel costs are not included.
Deadline and Submission: Submission deadline: February 6, 2015
Entries must be:
- Submitted via email to [email protected] OR
- Mailed to:
Center for Health & Pharmaceutical Law & Policy
Attn: Catherine Finizio
Seton Hall Law School
One Newark Center
Newark, NJ 07102
Direct any questions to: 973-642-8871 or [email protected]
Please visit law.shu.edu/compliance.
|
|
For information on additional opportunities, please visit our website.
|
|
|
